162 related articles for article (PubMed ID: 32780197)
1. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer.
Yang H; Hu J; Chen J; Chen Z; Jiao F; Cui J; Quan M; Wang L
Med Oncol; 2020 Aug; 37(9):84. PubMed ID: 32780197
[TBL] [Abstract][Full Text] [Related]
2. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression.
Quan M; Chen Z; Jiao F; Xiao X; Xia Q; Chen J; Chao Q; Li Y; Gao Y; Yang H; Wang L; Cui J
J Exp Clin Cancer Res; 2020 Jan; 39(1):13. PubMed ID: 31941533
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
5. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
[TBL] [Abstract][Full Text] [Related]
6. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract][Full Text] [Related]
7. Novel KDM2B/SAV1 Signaling Pathway Promotes the Progression of Gastric Cancer.
Li N; Song H; Chen Z; Chen C; Quan M
Genet Res (Camb); 2023; 2023():1230182. PubMed ID: 37033161
[TBL] [Abstract][Full Text] [Related]
8. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway.
Pu N; Gao S; Yin H; Li JA; Wu W; Fang Y; Zhang L; Rong Y; Xu X; Wang D; Kuang T; Jin D; Yu J; Lou W
Cancer Lett; 2019 Sep; 460():42-53. PubMed ID: 31233838
[TBL] [Abstract][Full Text] [Related]
9. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
10. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
11. Protein salvador homolog 1 acts as a tumor suppressor and is modulated by hypermethylation in pancreatic ductal adenocarcinoma.
Wang L; Wang M; Hu C; Li P; Qiao Y; Xia Y; Liu L; Jiang X
Oncotarget; 2017 Sep; 8(38):62953-62961. PubMed ID: 28968962
[TBL] [Abstract][Full Text] [Related]
12. The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary.
Lyu Z; Qin N; Tyasi TL; Zhu H; Liu D; Yuan S; Xu R
PLoS One; 2016; 11(8):e0160896. PubMed ID: 27505353
[TBL] [Abstract][Full Text] [Related]
13. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
14. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
15. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
Ni L; Luo X
Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
[TBL] [Abstract][Full Text] [Related]
16. MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis.
Cui J; Zhou Z; Yang H; Jiao F; Li N; Gao Y; Wang L; Chen J; Quan M
Mol Cancer Res; 2019 Jun; 17(6):1316-1325. PubMed ID: 30796177
[TBL] [Abstract][Full Text] [Related]
17. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
18. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
Li Z; Jin H; Mao G; Wu L; Guo Q
Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
[TBL] [Abstract][Full Text] [Related]
19. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
20. A WW Tandem-Mediated Dimerization Mode of SAV1 Essential for Hippo Signaling.
Lin Z; Xie R; Guan K; Zhang M
Cell Rep; 2020 Sep; 32(10):108118. PubMed ID: 32905778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
